Vegetable Gum Soft Capsule for Blood Lipid Management
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current healthcare foods for managing hyperlipidemia, such as oral liquids, tablets, and gelatin soft capsules, face issues like inconvenience, poor stability, short storage time, and inadequate disintegration time, along with suboptimal selection of functional ingredients, which are not effective in significantly reducing blood lipid levels.
Innovation Solution
A blood lipid-lowering composition comprising echium seed oil, camelina seed oil, and safflower seed oil, in specific mass ratios, which are used to form a natural composition that effectively reduces serum total cholesterol and triglycerides, increases serum apolipoprotein A1 levels, and is formulated into a soft capsule with vegetable gums for improved bioavailability and stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional healthcare foods (oral liquid, tablet, animal glue soft capsule) are used for managinghyperlipidemia, then they are available in the market, but they have poor stability, short storage time, long disintegration time, and inadequate blood lipid-lowering efficacy
Solution Approach 1:
The patent changes the physical and chemical parameters of the capsule shell by replacing traditional gelatin with vegetable gum (such as sodium alginate, carrageenan, or pectin). This parameter change results in improved stability, extended storage time, and maintained disintegration performance while enabling better blood lipid-lowering efficacy through the encapsulation of specific functional oils
Solution Approach 2:
The patent uses composite materials by combining vegetable gum with specific functional oils (echium seed oil, camelina seed oil, and safflower seed oil in a mass ratio of (95-60):(40-6):(20-2)). This composite formulation creates a stable encapsulation system that protects the sensitive oil components while maintaining disintegration properties and enhancing blood lipid-lowering effects
2Ease of manufacture
If tablets are made with large doses of excipients such as starch and hydroxymethyl cellulose, then they are easy to manufacture, but they cause long disintegration time
Solution Approach 1:
The patent extracts and removes the problematic excipients (starch and hydroxymethyl cellulose) from the formulation by completely replacing them with vegetable gum-based soft capsule technology. This extraction eliminates the long disintegration time issue while maintaining ease of manufacture through the soft capsule production process
Solution Approach 2:
The patent adopts a disposable soft capsule design where the vegetable gum shell is engineered to dissolve completely and rapidly in the gastrointestinal tract. This approach sacrifices the long-term structural stability of traditional tablets in exchange for rapid disintegration and complete dissolution, achieving both ease of manufacture and short disintegration time
3Stability of the object's composition
If animal glue soft capsule is used, then it provides encapsulation protection, but it has long disintegration time and is not suitable for all populations
Solution Approach 1:
The patent inverts the traditional approach by replacing animal-derived gelatin with plant-based vegetable gum. This inversion maintains the encapsulation protection function while making the product suitable for all populations including vegetarians, religious groups avoiding animal products, and those with gelatin allergies, thereby achieving both protection and universal adaptability
4Ease of manufacture
If existing functional ingredients are used in healthcare foods, then they are commonly available, but they do not significantly reduce blood lipid levels
Solution Approach 1:
The patent merges three specific functional oils (echium seed oil, camelina seed oil, and safflower seed oil) in a precise mass ratio of (95-60):(40-6):(20-2). This combination creates a synergistic effect where the complementary fatty acid profiles and bioactive components of each oil work together to achieve significant blood lipid-lowering efficacy that exceeds the sum of individual components, while all ingredients remain naturally available
Data Source
AI summary
The present disclosure relates to the field of food and/or drug technology. Disclosed is a blood lipid-lowering composition, method for preparing the same and use thereof. The blood lipid-lowering composition comprises echium seed oil, camelina seed oil and safflower seed oil. The specific natural substances echium seed oil, camelina seed oil and safflower seed oil are used as the functional ingredients to form a natural composition that can significantly reduce the total cholesterol and triglyceride levels and increase the content of the serum apolipoprotein A1, having an obvious blood lipid-lowering function, which may be used in developing and preparing blood lipid-lowering drugs and foods, especially health care foods.